Treatment of obesity-related HFpEF: a STEP closer to the SUMMIT
- PMID: 40055143
- PMCID: PMC11980504
- DOI: 10.1080/14796678.2025.2477429
Treatment of obesity-related HFpEF: a STEP closer to the SUMMIT
Keywords: Obesity; heart failure; mortality; semaglutide; tirzepatide; treatment.
Conflict of interest statement
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
References
-
- NCD Risk Factor Collaboration (NCD-RisC) . Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027–1050. doi: 10.1016/S0140-6736(23)02750-2 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources